Kilitch Drugs (India) Limited Reports 69.87% Increase In Q4 Fy23 Profit
New Delhi (India), June 3: Kilitch Drugs India Limited is a Leading MSME multinational manufacturer of Injectable in India and Ethiopia, has announced its audited Financial Results for the Q4 & FY23. Financials at a Glance: Q4 FY23: • Total Revenue of ₹ 43.28 crore, YoY growth of 35.12% • EBITDA of ₹ 8.12 crore, YoY growth of 71.31% • EBITDA Margin is 18.76%, YoY growth of 396 Bps. • Net Profit of ₹ 5.13 crore, YoY growth of 69.87% […]
Continue Reading